Genetic Analysis AS, the molecular diagnostics company, has launched its GA-map microarray test for high throughput screening of infant gutmicrobiota. At the recent Sackler Colloquium on Microbes and Health, the company presented data from evaluation screens that show its potential as a tool for probing the mechanisms of disease in conditions associated with the gut flora.
Q Chip Ltd and ARTES Biotechnology GmbH announce that they have signed a Collaborative Agreement to explore the co-development of a new sustained release formulation of interferon alpha 2a for the treatment of chronic hepatitis B and C.
Cancer Research Technology (CRT) – Cancer Research UK's development and commercialisation arm has teamed up with The University of Auckland to advance the discovery of new molecular targeted compounds for the treatment of leukaemia.
Eurand, a specialty pharmaceutical company that develops, manufactures and commercializes enhanced pharmaceutical and biopharmaceutical products based on its proprietary pharmaceutical technologies, announced today that Eurand Inc. has signed three new commercialization, license and supply agreements for its novel extended-release (ER) formulation of the muscle relaxant cyclobenzaprine HCl. Financial terms were not disclosed.
Eurand, a specialty pharmaceutical company that develops enhanced pharmaceutical and biopharmaceutical products based on its proprietary pharmaceutical technologies, announced today that the Dutch Medicines Evaluation Board (MEB) informed the Company that the Decentralized Procedure (DCP) for registration of Paracetamol 250 and 500 mg Orodispersible Tablets (ODT) in several EU countries has been successfully completed.
Cresset is delighted to announce the appointment of Dr Rob Scoffin as chief executive officer of Cresset Group. Rob joins Cresset from CambridgeSoft where, as vice president of European Operations, he was responsible for significant growth in CambridgeSoft's European business. Rob replaces Beatrice Leigh, who will now become non-executive Chairman of the Board.
Frickenhausen, [18 March 2010] – Greiner Bio-One GmbH is introducing the novel Datamatrix Cryo Rack at the Analytica 2010 in Munich. Up to 48 Cryo.s freezing vials can be scanned simultaneously in this new rack, thus enabling automated and efficient sample handling.
Eurand, a global specialty pharmaceutical company, today reported revenues for the fourth quarter of 2009 of €30.3 million ($43.4 million), a 28% increase in constant currency from the fourth quarter of 2008. For the year ended 31 December 2009, revenues grew to a record €120.6 million ($172.8 million), up 18% in constant currency from 2008.
Eurand, a global specialty pharmaceutical company, has announced the grant of U.S. Patent No. 7,658,918, titled Stable Digestive Enzyme Compositions, by the United States Patent and Trademark Office (USPTO).
Core laboratories RadPharm and Medifacts International recently merged business operations, hoping to attract new clients with their combined portfolios.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.